Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
Meelad I H Al-JazairiBao-Oanh NguyenRuben R De WithMarcelle D SmitBob WeijsAnne H HobbeltMarco AlingsJan G P TijssenBastiaan GeelhoedHans L HillegeRobert G TielemanDirk J Van VeldhuisenHarry J G M CrijnsIsabelle C Van GelderYuri BlaauwMichiel Rienstranull nullPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
In stable HF patients with early persistent AF, AAD treatment was effective in nearly half of patients, with no serious adverse effects reported.